Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model

被引:17
|
作者
Tammiruusu, A.
Penttila, T.
Lahesmaa, R.
Sarvas, M.
Puolakkainen, M.
Vuola, J. M.
机构
[1] Natl Publ Hlth Inst, Infect Pathogenesis Lab, Dept Viral Dis & Immunol, FIN-00300 Helsinki, Finland
[2] Univ Helsinki, HUSLAB, Diagnost Lab, Haartman Inst,Dept Virol, FIN-00014 Helsinki, Finland
[3] Turku Univ, Turku Ctr Biotechnol, FIN-20520 Turku, Finland
[4] Abo Akad Univ, FIN-20520 Turku, Finland
[5] Natl Publ Hlth Inst, Dept Vaccines, FIN-00300 Helsinki, Finland
基金
芬兰科学院;
关键词
Chlamydia pneunoniae; CopN; immunization;
D O I
10.1016/j.vaccine.2006.07.043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia pneunioniae is an intracellular pathogen that grows inside a vacuole, referred to as an inclusion. C. pnetanoniae possess a type III secretion system (TTSS), which allows them to secrete effector molecules into the inclusion membrane and to the host cell cytosol. Proteins such as chlamyclial outer protein N (CopN) that associate with the inclusion membrane are potential targets for the host's MHC-dependent antigen presentation. thereby representing ideal antigen candidates for T cell-based vaccination. The results of this study showed that intranasal immunization of BALB/c mice with heat-aggregated CopN protein and an Escherichia coli heat-labile toxin (LT) induced a strong immune response. detected as antigen-specific antibody production, lymphocyte proliferation and IFN-gamma production. Furthermore, the immunization induced statistically significant protection against intranasal C. pneunioniae challenge, the level of which correlated with the magnitude of CopN-specific lymphocyte proliferation. Both heat-aggregation of the antigen and the presence of LT adjuvant were required for maximal protective effect. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 50 条
  • [41] A vaccine formulated with the Chlamydia trachomatis (Ct) recombinant major outer membrane protein (rMOMP) and TLR2 and TLR9 agonists as adjuvants elicits strong protection against an intranasal challenge
    Cheng, Chunmei
    Pal, Sukumar
    Tifrea, Delia
    de la Maza, Luis
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [42] A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P-aeruginosa in a murine model of chronic pulmonary infection
    Staczek, J
    Gilleland, HE
    Gilleland, LB
    Harty, RN
    García-Sastre, A
    Engelhardt, OG
    Palese, P
    INFECTION AND IMMUNITY, 1998, 66 (08) : 3990 - 3994
  • [43] Immunization Against Chlamydia trachomatis Polymorphic Membrane Protein D Tetrapeptide Motifs Limits Early Female Reproductive Tract Infection in a Mouse Model
    Collar, Amanda L.
    Jamus, Andzoa N.
    Flanagan, Julian
    Core, Susan B.
    Geisler, William M.
    Wheeler, Cosette M.
    Frietze, Kathryn M.
    VACCINES, 2025, 13 (03)
  • [44] Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein
    Olsen, Anja W.
    Follmann, Frank
    Erneholm, Karin
    Rosenkrands, Ida
    Andersen, Peter
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (06): : 978 - 989
  • [45] Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen a fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice
    Pimenta, F. C.
    Miyaji, E. N.
    Areas, A. P. M.
    Oliveira, M. L. S.
    de Andrade, A. L. S. S.
    Ho, P. L.
    Hollingshead, S. K.
    Leite, L. C. C.
    INFECTION AND IMMUNITY, 2006, 74 (08) : 4939 - 4944
  • [46] Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon
    Troy, Amber
    Esparza-Gonzalez, Sandra C.
    Bartek, Alicia
    Creissen, Elizabeth
    Izzo, Linda
    Izzo, Angelo A.
    TUBERCULOSIS, 2020, 123
  • [47] Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection
    Kochinger, Stefanie
    Renevey, Nathalie
    Hofmann, Martin A.
    Zimmer, Gert
    VETERINARY RESEARCH, 2014, 45
  • [48] Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection
    Stefanie Kochinger
    Nathalie Renevey
    Martin A Hofmann
    Gert Zimmer
    Veterinary Research, 45
  • [49] Nasopharyngeal exposure to Streptococcus pneumoniae induces extended age-dependent protection against pulmonary infection mediated by antibodies and CD138+ cells (vol 200, pg 3739, 2018)
    Ghanem, Bou E. N.
    Maung, N. H. T.
    Siwapornchai, N.
    Goodwin, A. E.
    Clark, S.
    Munoz-Elias, E. J.
    Camilli, A.
    Gerstein, R. M.
    Leong, J. M.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (11): : 3471 - 3471
  • [50] OUTER-MEMBRANE PROTEIN-F PREPARATION OF PSEUDOMONAS-AERUGINOSA AS A VACCINE AGAINST CHRONIC PULMONARY INFECTION WITH HETEROLOGOUS IMMUNOTYPE STRAINS IN A RAT MODEL
    GILLELAND, HE
    GILLELAND, LB
    MATTHEWSGREER, JM
    INFECTION AND IMMUNITY, 1988, 56 (05) : 1017 - 1022